Demographic and clinical correlates of sexual dysfunction among Nigerian male outpatients on conventional antipsychotic medications

BMC Research Notes

Timothy Olaolu Adebowale²  Olukayode Abayomi¹  Adegoke Oloruntoba Adelufosi¹  Aina Kikelomo Oyekanmi² 

[1] Ladoke Akintola University Teaching Hospital, Ogbomoso, Oyo State, Nigeria;Neuropsychiatric Hospital, Aro, P.O Box 2210, Sapon, Abeokuta, Ogun State, Nigeria

关键词: Schizophrenia;    Conventional antipsychotics;    Sexual dysfunction;   

Others  :  1166373
DOI  :  10.1186/1756-0500-5-267

 received in 2012-03-28, accepted in 2012-05-28,  发布年份 2012

【 摘 要 】

Background

In psychotic disorders, early intervention with antipsychotic medications increases the likelihood of favourable long-term course. However, the pharmacologic management especially with conventional antipsychotic medications is complicated by a high rate of adverse effects including sexual dysfunction. This study aims to determine the demographic and clinical factors associated with sexual dysfunction among male psychiatric outpatients on conventional antipsychotic medications in South-western Nigeria.

Methods

Two hundred and seventy five consecutive male outpatients with psychotic disorders on conventional antipsychotic medications were interviewed. Data was collected on demographic characteristics, illness-related and medication-related variables. Illness severity was assessed with the Brief psychiatric rating scale. The International Index of Erectile Function questionnaire was used to assess for sexual dysfunctions.

Results

A total of 111 (40.4%) respondents had one or more forms of sexual dysfunction. Sexual desire dysfunction was present in 47 (17.1%) of respondents, erectile dysfunction in 95 (34.5%), orgasmic dysfunctions in 51 (18.5%), intercourse dissatisfaction in 72 (26.2%) and overall dissatisfaction in 64 (23.3%). Sexual dysfunction was significantly associated with employment status, age, marital status, haloperidol use, medication dosage, and presence of psychopathology. Unemployment was the only significant independent correlate of sexual dysfunction, with unemployed respondents twice more likely to have sexual dysfunction compared with those employed (Wald = 3.865, Odds Ratio = 2.033, 95% confidence interval = 1.002 - 4.124, p = 0.049).

Conclusions

The high prevalence of sexual dysfunction found in this study suggests a need among clinicians for increased awareness and recognition of the sexual side effects in patients taking conventional antipsychotic medications. This knowledge should guide conventional antipsychotic medication prescription in the at-risk population to improve treatment adherence.

【 授权许可】

   
2012 Oyekanmi et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Aizenberg D, Modai I, Landa A, et al.: Comparison of sexual dysfunction in male schizophrenic patients maintained on treatment with classical antipsychotics versus clozapine. J Clin Psychiatry 2001, 62(7):541-544.
• [2]Cutler AJ: Sexual dysfunction and antipsychotic treatment. Psychoneuroendocrinology 2003, 28(Suppl 1):69-82.
• [3]Wesby R, Bullimore E, Earle J, Heavey A: A survey of psychosexual arousability in male patients on depot neuroleptic medication. Eur Psychiatry 1996, 11:81-86.
• [4]Milner K, Tandon R, Tomori O, Florence T: Psychotropic medications and sexual dysfunction. In Sexuality and Serious Mental Illness. Edited by Buckley PF. Harwood Academic Publishers, Amsterdam; 1999.
• [5]Menon A, Williams RH, Watson S: Increased libido associated with quetiapine. J Psychopharm 2006, 20(1):125-127.
• [6]Ucok A, Incesu C, Aker T, Erkoc S: Sexual dysfunction in patients with schizophrenia on antipsychotic medication. Eur Psychiatry 2007, 22:328-333.
• [7]Fujii A, Yasui-Furukori N, Sugawara N, Sato Y, Nakagami T, Saito M, Kaneko S: Sexual dysfunction in Japanese patients with schizophrenia treated with antipsychotics. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34:288-293.
• [8]Smith SM, O’Keane V, Murray R: Sexual dysfunction in patients taking conventional antipsychotics. Br J Psychiatry 2002, 181:49-55.
• [9]Fakhoury WK, Wright D, Wallace M: Prevalence and extent of distress of adverse effects of antipsychotics among callers to a United Kingdom National Mental Health Helpline. Int Clin Psychopharmacol 2001, 16(3):153-162.
• [10]Knegtering H, Boks M, Blijd C, Castelein S, Van den Bosch RJ, Wiersma DA: Randomized open-label comparison of the impact of olanzapine versus risperidone on sexual functioning. J Sex Marital Ther 2006, 32:315-326.
• [11]Ghadirian AM, Chouinard G, Annable L: Sexual dysfunction and plasma proclatinlevels in neuroleptic-treated schizophrenic outpatients. J Nerv Mental Disease 1982, 170:463-467.
• [12]Segraves RT: Effects of psychotropic drugs on human erection and ejaculation. Arch Gen Psychiatry 1989, 46(3):275-284.
• [13]Gitlin MJ: Psychotropic medications and their effects on sexual function: diagnosis, biology, and treatment approaches. J Clin Psychiatry 1994, 55:406-413.
• [14]Aviv A, Shelef A, Weizman A: An open-label trial of sildenafil addition in risperidone– treated male schizophrenia patients with erectile dysfunction. J Clin Psychiatry 2004, 65(1):97-103.
• [15]Gopalakrishnan R, Jacob KS, Kuruvilla A, Vasantharaj B, John JK: Sildenafil in the treatment of antipsychotic induced erectile dysfunction: a randomized, double-blind, placebo-controlled, flexible-dose, two-way crossover trial. Am J Psychiatry 2006, 163(3):494-499.
• [16]Modebe O: Erectile failure among medical clinic patients. Afr J Med Science 1990, 19:259-264.
• [17]Okulate G, Oladokun O, Dogunro AS: Erectile dysfunction: Prevalence and relationship with depression, alcohol abuse and Panic disorder. Gen Hosp Psychiatry 2003, 25(3):209-213.
• [18]Adegunloye OA, Makanjuola AB, Adelekan ML: Sexual dysfunction among secondary school teachers in Ilorin, Nigeria. J Sex Med 2010, 7:3835-3844.
• [19]Mosaku KS, Ukpong DI: Erectile dysfunction in a sample of patients attending a psychiatric outpatient department. Int J Impotence Res 2009, 21:235-239.
• [20]Overall JE, Gorham DR: The Brief Psychiatric Rating Scale. Psychol Reports 1962, 10:799-812.
• [21]Adewuya AO, Owoeye AO, Erinfolami AO, Ola BA: Correlates of self-stigma among outpatients with mental illness in Lagos, Nigeria. Int J Soc Psychiatry 2011, 57(4):418-427.
• [22]Rosen RC, Riley A, Wagner G, et al.: The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997, 49(6):822-830.
• [23]Adamson TA: Prescribing habits for psychiatric in-patient admissions in a Nigerian psychiatric hospital. Afr J Med Sci 1995, 24:261-265. ref for pg 74
• [24]Hiroto I, Asuka K, Teruhiko H: Polypharmacy and excessive dosing: psychiatrists' perceptions of antipsychotic drug prescription. Br J Psychiatry 2005, 187:243-247.
• [25]Harrington M, Lelliott P, Paton C, et al.: The result of a multicentre audit of the prescribing of antipsychotic drugs for in-patient in the U.K. Psychiatr Bull 2002, 26:414-418.
• [26]Collins AC, Kellner R: Neuroleptics and sexual functioning. Integr Psychiatry 1986, 4:96-108.
• [27]Teusch L, Scherbaum N, Bohme H, et al.: Different patterns of sexual dysfunctions associated with psychiatric disorders and psychopharmacological treatment. Results of an investigation by semi structured interview of schizophrenic and neurotic patients and methadone-substituted opiate addicts. Pharmacopsychiatry 1995, 28(3):84-92.
• [28]Khawaja MY: Sexual dysfunction in male patients taking antipsychotics. J Ayub Med Coll 2005, 17(3): .
• [29]Abdo CHN, Oliveira Júnior WM, Júnior EM, Abdo JA, Fittipaldi JAS: The impact of psychosocial factors on the risk of erectile dysfunction and inhibition of sexual desire in a sample of the Brazilian population. Sao Paulo Med J 2005, 123(1):11-14.
• [30]Adelufosi AO, Adebowale TO, Abayomi O, Mosanya JT: Medication adherence and quality of life among Nigerian outpatients with Schizophrenia. Gen Hosp Psychiatry 2012, 34:72-79.